About Aavogen
Biotech startup that develops gene therapeutics for muscle wasting diseases. This includes inclusion body myositis, muscular dystrophies, peripheral nerve damage and more. At Aavogen, we make you stronger!
Headquarters
Rockville, MDWebsite
http://www.aavogen.comCompany Size
2-10 employeesIndustry
Biotechnology ResearchCompany Type
Privately HeldFounded
2025Specialties
gene therapy, muscle biology, regenerative medicine, muscular dystrophy, and cachexia